A Prospective Randomized Study on the Risk of Bacteremia in Banding versus Sclerotherapy of Esophageal Varices by Marc J. Zuckerman et al.
May 2016 | Volume 3 | Article 161
Original research
published: 02 May 2016
doi: 10.3389/fmed.2016.00016
Frontiers in Medicine | www.frontiersin.org
Edited by: 
Yeong Yeh Lee, 
Universiti Sains Malaysia, Malaysia
Reviewed by: 
Chai Soon Ngiu, 
Universiti Kebangsaan Malaysia, 
Malaysia 
Thevaraajan Jayaraman, 
Universiti Teknologi MARA (UiTM), 
Malaysia
*Correspondence:
Marc J. Zuckerman  
marc.zuckerman@ttuhsc.edu
Specialty section: 
This article was submitted 
to Gastroenterology, 
a section of the journal 
Frontiers in Medicine
Received: 23 February 2016
Accepted: 11 April 2016
Published: 02 May 2016
Citation: 
Zuckerman MJ, Jia Y, Hernandez JA, 
Kolli VR, Norte A, Amin H, 
Casner NA, Dwivedi A and Ho H 
(2016) A Prospective Randomized 
Study on the Risk of Bacteremia in 
Banding versus Sclerotherapy of 
Esophageal Varices. 
Front. Med. 3:16. 
doi: 10.3389/fmed.2016.00016
a Prospective randomized study
on the risk of Bacteremia in  
Banding versus sclerotherapy of 
esophageal Varices
  
 
Marc J. Zuckerman1*, Yi Jia1, Jesus A. Hernandez1, Venkateswara R. Kolli1, Arturo Norte1, 
Hemal Amin1, Nancy A. Casner1, Alok Dwivedi 2 and Hoi Ho 3
1 Division of Gastroenterology, Texas Tech University Health Sciences Center, El Paso, Texas, USA, 2 Division of Biostatistics 
and Epidemiology, Texas Tech University Health Sciences Center, El Paso, Texas, USA, 3Division of Infectious Disease, Texas 
Tech University Health Sciences Center, El Paso, Texas, USA
Background: Esophageal variceal banding may be less likely to cause bacteremia than 
sclerotherapy. The existing data about the frequency of bacteremia after esophageal 
variceal banding are conflicting, and few studies include both banding and sclerotherapy.
aims: We conducted a prospective randomized controlled trial to compare the frequency 
of bacteremia after esophageal variceal banding and sclerotherapy.
Methods: Over a 2-year period, patients with liver disease admitted for upper gastroin-
testinal bleeding or for outpatient elective variceal therapy were enrolled. New patients 
were randomized preprocedure to either banding or sclerotherapy, and subsequent 
sessions utilized the initial procedure. The groups consisted of banding, sclerotherapy, 
and endoscopy without variceal therapy. Subjects underwent endoscopy by one out of 
three gastroenterologists. Blood cultures were obtained 5 min before and 30 min after 
endoscopy to check for bacteremia.
results: Postendoscopic blood cultures were positive following 4 out of 139 (2.9%) 
sessions: 1 sclerotherapy and 3 control sessions. All postendoscopic positive blood 
cultures were found following emergency sessions (4/92, 4.3%). One pre-endoscopic 
blood culture was positive in a patient with emergency banding. The rates of positive 
postendoscopic blood cultures among groups with emergency banding (0/22, 0%), 
emergency sclerotherapy (1/41, 2.3%), and emergency control (3/29, 10.3%) were 
not significantly different. Postendoscopic positive blood cultures were not found after 
elective sessions with either banding or sclerotherapy.
conclusions: Postendoscopic bacteremia was infrequent following emergency endos-
copy in patients with esophageal variceal bleeding. Bacteremia was not found after 
esophageal variceal banding, although this was not significantly less frequent than after 
sclerotherapy. Postendoscopic bacteremia was not associated with elective variceal 
therapy.
Keywords: bacteremia, banding, esophageal varices, sclerotherapy, cirrhosis
Abbreviations: EVL, esophageal band ligation; EVS, esophageal variceal sclerotherapy; UGI, upper gastrointestinal.
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inTrODUcTiOn
Endoscopic therapy is the most reliable treatment for esophageal 
varices, for both active bleeding and prevention of re-bleeding 
(1). Endoscopic variceal ligation (EVL) has replaced endoscopic 
variceal sclerotherapy (EVS) as a treatment for esophageal varices 
(2). Bacteremia can occur after any endoscopic procedure, 
including diagnostic esophagogastroduodenoscopy, as the result 
of bacterial translocation of endogenous microbial flora into 
the bloodstream (3–5). There has been concern about the risk 
of infectious adverse events after endoscopic therapy of varices. 
However, the incidence of bacteremia after EVL in patients with 
cirrhosis or portal hypertension is reported to be low and with 
few adverse events (6–8). Although there have been reports of 
infection with both EVL and EVS procedures, the incidence of 
transient bacteremia after EVL (3–6%) (6–9) may be lower than 
that after EVS (0–53%) (9–12). Moreover, the total incidence of 
all types of infectious adverse events after EVL (1.8%) may be 
lower than for EVS (18%) (6). A retrospective study has implied 
that the rate of clinical bacterial peritonitis after EVL may also be 
lower (6). However, the existing data are conflicting due to small 
sample sizes and variable controls (6–11).
In current guidelines addressing the risk of bacteremia with 
endoscopic variceal therapy, we noted the limited data on bac-
teremia with EVL (5, 13–15). We previously studied the risk of 
bacteremia in sclerotherapy of esophageal varices and reported 
clinically important postendoscopic bacteremia in 10.6% of the 
emergency sclerotherapy sessions. After EVL was introduced, we 
designed this prospective randomized study to compare the rate 
of bacteremia after endoscopic esophageal variceal ligation with 
that of sclerotherapy.
MaTerials anD MeThODs
subjects
Patients with liver disease admitted for UGI bleeding or for 
outpatient elective variceal therapy with previous EVS and 
EVL at Thomason General Hospital in El Paso, TX, USA were 
included in the study (Figure 1). Patients were excluded if they 
had received any antibiotics in the last 2 weeks before inclusion 
in the study. Patients were enrolled and underwent endoscopy by 
one out of three gastroenterologists (Marc J. Zuckerman, Jesus A. 
Hernandez, and Venkateswara R. Kolli). New patients were ran-
domized preprocedure to either banding or sclerotherapy, and 
subsequent sessions utilized the initial procedure. The study was 
approved by the Texas Tech University Health Sciences Center 
Institutional Review Board, and informed consent was obtained 
before patients entered the study.
A total of 139 (63 emergency variceal therapy, 47 elective 
variceal therapy, and 29 emergency endoscopy control) endos-
copies were performed in 94 patients. The emergency groups 
consisted of all patients who underwent endoscopy within 24 h 
of admission or within 24 h of re-bleeding in hospital. The elec-
tive group consisted of all patients without UGI bleeding at the 
time of admission and admitted to the hospital for the follow-
up endoscopic procedures. There were five groups of patients: 
(a) emergency endoscopy with sclerotherapy, 41 sessions in 
30  patients; (b) elective endoscopy with sclerotherapy, 29 ses-
sions in 18 patients; (c) emergency endoscopy with banding, 22 
sessions in 20 patients; (d) elective endoscopy with banding, 18 
sessions in 11 patients; and (e) endoscopy without banding or 
sclerotherapy (patients suspected of having UGI bleeding due to 
esophageal varices, but found to have another source, controls), 
29 sessions in 29 patients.
endoscopy
Patients were premedicated with IV diazepam or midazolam 
and at times, meperidine. Endoscopy was performed with 
Olympus GIF endoscopes (Olympus, Lake Success, NY, USA). 
Sclerotherapy was performed with a 25-gage, 4-mm disposable 
flexible injector (Flexitip Retractable Sclerotherapy needle no 
198; American Endoscopy, Inc., Mentor, OH, USA) and sodium 
tetradecyl sulfate 1.5% (Elkins-Sinn Inc., Cherry Hill, NJ, USA) 
in D50W sclerosant. Injections were administered intravariceally 
with an average of 2 mL of sclerosant (range, 1–3 mL) per injec-
tion. EVL was performed using an overtube and the Steigman–
Goff single band ligator (Bard Interventional Products, Billerica, 
MA, USA). A 25-cm overtube was backloaded over the shaft of 
the endoscope. After the endoscope entered the esophagus, the 
overtube was pushed forward over the shaft of the endoscope. 
The endoscopic ligating device was subsequently attached to the 
distal end of the endoscope. Each varix was ligated with one rub-
ber band or until the bleeding stopped. During elective sessions, 
individual ligation sites were gradually reduced until the varices 
were too small to ligate.
Blood cultures
Blood cultures (total 415 blood cultures obtained in 139 sessions) 
were drawn via separate venous punctures of the forearm at 5 min 
(BCX1) before endoscopy and 30 min (BCX3) after the endoscopy. 
The blood cultures were taken by the research coordinator (AN) 
after the patient’s forearm was cleansed with povidone-iodine and 
70% isopropyl alcohol. Blood, 5  mL, was inoculated into each 
Trypticase Soy Broth bottle (Becton Dickinson, Towson, MD, 
USA) for both aerobic and anaerobic cultures. Bacterial growth 
was monitored radiometrically for 7  days with the Bactec 360 
Microscan system (Baxter, West Sacramento, CA, USA).
Data analysis
Continuous data were described using mean and SD, whereas 
categorical data were described using frequency and propor-
tion. Baseline characteristics were compared among groups. 
Continuous data were compared using the one-way analysis of 
variance (ANOVA), whereas categorical data were compared 
using Fisher’s exact test. The outcome, risk of bacteremia, 
was compared first looking at the risk of bacteremia between 
sclerotherapy with banding using Fisher’s exact test. After this, 
the intervention group (EVS or EVL) was compared with the 
control group for risk of bacteremia using Fisher’s exact test. 
In the secondary analysis, emergency and elective groups were 
also compared for risk of bacteremia using Fisher’s exact test. 
Finally, five groups were compared using Fisher’s exact test. All 
the p-values less than 5% were considered as significant results. 
Statistical analysis was carried out using STATA 12.1.
Patients with liver disease admitted for 
upper GI bleeding
Exclusion: Received any antibiotics in the last 2 weeks before
Emergency EVS (30) Emergency EVL (20) 
Outcome: The frequency of bacteremia at before, 5 and 30 minutes after endoscopy
Subsequent 
elective EVS (8)
Emergency Endoscopy (79) 
Candidate for 
variceal therapy (50)
Not candidate for 
variceal therapy (29)
Subsequent 
elective EVL (6)
Control Group (29)
Randomized
Elective EVS (10) 
Outpatient elective variceal therapy 
with previous EVS and EVL
Elective EVL (5) 
Total elective EVS (18) Total elective EVL (11) 
FigUre 1 | Flowchart of the study design. Note: EVS, endoscopic variceal sclerotherapy; EVL, endoscopic variceal ligation. The number of patients is reported 
in parenthesis ().
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resUlTs
A total of 139 endoscopy sessions were performed in a total of 94 
patients enrolled in the study (Table 1). The emergency variceal 
therapy endoscopies were performed in 63 sessions in 50 patients 
(41 sessions in 30 patients with EVS, and 22 sessions in 20 
patients with EVL). The elective variceal therapy had 47 sessions 
in 29 patients (29 sessions in 18 patients with EVS and 18 ses-
sions in 11 patients with EVL). The control groups (29 sessions 
in 29 patients) included emergency endoscopies performed due 
to suspected esophageal varices, but patients were found to have 
other bleeding sources (Table 2).
The sclerotherapy, banding, and control groups were com-
parable in age (Table 1). Most patients had a history of alcohol 
abuse as the main etiology of liver disease. The average Child-
Pugh score was 7.6 in both the EVL and EVS groups and 7.3 
in the control group. Active bleeding was 10.5% in emergency 
sclerotherapy, 10.0% in emergency banding, and 15.4% in the 
control group. Both the EVL and emergency endoscopy groups 
had a longer duration of procedure time than the EVS group 
(p = 0.018). The average number of injections was six in patients 
with sclerotherapy, and the average number of bands placed was 
five in the patients who had banding.
Positive postendoscopic blood cultures were found from 6 out 
of 415 blood cultures (14.5%) (Table 3). The bacteremia rate after 
endoscopic procedures was 4.3%, found in 4 out of 92 emergency 
sessions. For elective endoscopy sessions, no positive blood 
culture was found after either 18 banding or 29 sclerotherapy 
sessions.
There were no significant differences in the rates of pos-
tendoscopic bacteremia between the sclerotherapy (1/70) and 
banding (0/40) method (Table 4). The rates of bacteremia were 
significantly higher in the emergency control (3/29) group than 
the variceal therapy (1/110) groups (p = 0.029).
The rates of bacteremia were not significantly different 
between emergency variceal therapy groups (1/63) and elective 
variceal therapy groups (0/47). There were also no significant 
differences in the rates of bacteremia comparing the five differ-
ent study groups, emergency EVS (1/41), elective EVS (0/29), 
emergency EVL (0/22), elective EVL (0/18), and emergency 
control (3/29).
The organisms isolated from each positive blood culture 
obtained either before or after endoscopy are listed in Table 5. 
One positive blood culture (Strep. intermedius) was obtained 
pre-endoscopy in a patient randomized to emergency banding. 
Five blood cultures from 4 patients in 139 sessions (2.9%) were 
positive. All the patients who had bacteremia after endoscopy 
were Child Class B. Active bleeding was present in one of the 
four patients.
Of these positive cultures, one was in an emergency sclero-
therapy session (Staph. aureus) and three were in emergency 
endoscopy control sessions (E. coli in one, Staph. epidermidis in 
two). Although we do not consider these to be patients with defi-
nite identifiable sources of infection, we summarize the clinical 
TaBle 5 | Bacteria isolated from blood culture before and after 
endoscopy.
Patient BcX 1 BcX 2 BcX 3
Emergency EVS
1 (144) – S. aureus –
Emergency EVL
1 (010) S. intermedius – –
Emergency endoscopy
1 (056) – E. coli
2 (081) – – S. epidermidis
3 (095) – S. epidermidis S. epidermidis
Of 415 blood cultures obtained (in 139 sessions), 6 were positive (in 5 sessions).
BCX, blood cultures – BCX1 (before), BCX2 (5 min), and BCX 3 (30 min).
Positive postendoscopic blood cultures were: one in an emergency sclerotherapy 
patient (Staph. aureus) and three in control patients (E. coli in one and Staph. 
epidermidis in two). One blood culture was positive pre-endoscopy in a patient 
randomized to emergency banding (Strep. intermedius).
TaBle 3 | number of sessions with positive blood culture results before 
and after endoscopy.
group BcX 1  
(%)
BcX 2  
(%)
BcX 3 
(%)
Total after 
endoscopy
Emergency EVS (41) 0 (0) 1 (2) 0 (0) 1 (2)
Elective EVS (29) 0 (0) 0 (0) 0 (0) 0 (0)
Emergency EVL (22) 1 (5) 0 (0) 0 (0) 0 (0)
Elective EVL (18) 0 (0) 0 (0) 0 (0) 0 (0)
Emergency endoscopy (control) (29) 0 (0) 2 (7) 2 (7) 4 (10)
BCX, blood culture – BCX1 (before), BCX2 (5 min), and BCX 3 (30 min).
TaBle 4 | comparisons of risk of bacteremia after endoscopy according 
to different groups.
group risk of bacteremia P-value
Positive negative
EVS versus EVL
EVS 1 69 1.000
EVL 0 40
Emergency
EVS 1 40 1.000
EVL 0 22
Elective
EVS 0 29 NA
EVL 0 18
Variceal therapy versus control 0.029
Variceal therapy (EVS/EVL) 1 109
Control 3 26
Emergency versus elective 1.000
Emergency EVS 1 62
Elective EVS 0 47
Overall comparison 0.162
Emergency EVS 1 40
Elective EVS 0 29
Emergency EVL 0 22
Elective EVL 0 18
Emergency endoscopy (control) 3 26
TaBle 2 | sources of Ugi bleeding in emergency endoscopy control 
group (n = 29).
source sessions  
number (%)
associated  
abnormalities
PHGa 6 (20.7) GU-1, esoph varices – 2
Gastric ulcerb 6 (20.7) Gastritis-2, esoph varices-1, DU-1
Mallory–Weiss tear 5 (17.2) PHG-1
Duodenal ulcerb 4 (13.8)
Erosive esophagitis 4 (13.8) Gastritis-2
Gastric erosions 3 (10.3) Esoph varices-1
Small esophageal 
varices
1 (3.4)
aPHG-portal hypertensive gastropathy.
bUlcers treated with Bicap (GU-2, DU-2).
Of the 29 sessions, 17 were in patients within 24 h of admission, 6 were in patients 
>24 h after admission, and 6 were indeterminate.
TaBle 1 | characteristics of sclerotherapy, banding, and control group 
sessions.
sclerotherapy Banding control P-value
Age (year) 49.1 ± 11.5 48.6 ± 12.0 50.1 ± 11.7 0.56
Sex (M/F) 65/5 29/11 26/3 0.01
Patients (n) (Total 40) (Total 25) (Total 29)
Emergency 30 20 29
Elective 18 11 0
Sessions (Total 70) (Total 40) (Total 29)
Emergency 41 22 29 –
Elective 29 18 0 –
Etiology 0.00
Alcohol 36 30 16 –
HCV 1 0 2 –
Alcohol/HCV 23 1 4 –
Alcohol/HCV/HBV 7 1 0 –
Other 3 8 9 –
Encephalopathy (A/B/C) 67/3/0 39/1/0 25/3/1 0.18
Ascites (A/B/C) 49/20/1 34/4/2 24/2/3 0.016
Bilirubin (mg/dL) 2.9 ± 4.4 2.1 ± 1.2 2.1 ± 1.7 0.34
Albumin (g/dL) 2.7 ± 0.8 2.6 ± 0.4 3.0 ± 0.9 0.14
Prothrombin time (s) 15.2 ± 2.6 15.0 ± 1.9 13.9 ± 1.9 0.054
Child-Pugh score 7.6 ± 1.9 7.6 ± 1.6 7.3 ± 2.4 0.70
Child class (A/B/C) 22/33/14 10/25/5 15/10/4 0.11
Active bleedinga 6.2% 5.4% 15.4% 0.27
Hematocrit (g/dL) 29.6 ± 7.2 28.9 ± 6.6 32.1 ± 7.3 0.17
Procedure time (min) 12.9 ± 4.8 16.4 ± 8.3 17.3 ± 10.7 0.018
Sclerosant vol (mL) 11.5 ± 4.8 – – n/a
Sclerosant inj (n) 6.1 ± 2.3 – – n/a
Bands (n) – 5.2 ± 2.1 – n/a
A total of 139 endoscopies were performed in 94 patients, 29 sessions were in the 
emergency endoscopy control group, and 110 in the endoscopic variceal therapy 
groups (63 emergency variceal therapy and 47 elective variceal therapy).
aActive bleeding was 10.5% for emergency sclerotherapy and 10.5%for emergency 
banding, p = 0.2 comparing the three emergency groups.
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context for each patient. One patient had positive cultures of 
Staph. epidermidis at both 5 and 30 min. This patient had red-
ness in the wrist at the intravenous access site without infectious 
complications after the procedure. The other patient with one 
positive culture of Staph. epidermidis developed pneumonia with 
5Zuckerman et al. Bacteremia in Banding versus Sclerotherapy
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sputum culture positive for Strep. pneumonia. These positive cul-
tures of Staph. epidermidis may be contaminants. The patient with 
positive culture of E. coli had abdominal pain and leukocytosis 
on admission before endoscopy and developed culture negative 
spontaneous bacterial peritonitis (SBP) after endoscopy. Although 
it is not clear whether the detected E. coli is clinically significant or 
the cause of SBP, the endoscopic procedure, is unlikely to be the 
source and the bacteremia may be secondary to pre-existing SBP. 
One patient in the emergency EVS group had a positive culture 
of Staph. aureus, which is likely to be a nosocomial infection with 
source undetected.
DiscUssiOn
In our prospective randomized controlled trial, postendoscopic 
bacteremia was infrequent following emergency endoscopy in 
patients with esophageal variceal bleeding. Bacteremia was not 
found after esophageal variceal banding, although this was not 
significantly less frequent than after sclerotherapy. Postendoscopic 
bacteremia was not associated with elective variceal therapy.
Patients with chronic liver disease and endoscopic procedures 
for esophageal varices are predisposed to bacteremia and infec-
tions (1, 16, 17). Several mechanisms of bacterial contamination 
have been proposed for endoscopy-related bacteremia (18, 19). 
Bacteremia has been detected as the transient contamination of 
oral or digestive pathogens (20), potential transluminal seeding 
from the EVS needle, a contamination of the side channel of the 
endoscope, or a contamination of sclerosants (19). The acute 
variceal hemorrhage itself can also provide possible mechanisms 
of bacterial contamination (18). The exposure to sclerosants 
is recognized as a foreign material and provides an ideal route 
for bacterial invasion, whereas infected sclerosants could form 
an anatomic path between the gastrointestinal lumen and the 
vascular spaces (19).
Many cases of bacteremia post EVS and EVL may be 
due to bacterial contamination from a skin source, such as 
Strep. pyogenes, Diphtheroid species, and coagulase-negative 
Staphylococcus (9–11, 21). Coagulase-negative Staphylococcus 
is one of the most frequent causes of nosocomial bloodstream 
infection and may be found in patients with no clinically signifi-
cant presentations (22). We reported three Staph. epidermidis 
blood cultures in two patients. Prior to endoscopy, one patient 
randomized to the emergency EVL group had Strep. interme-
dius, which is a commensal organism that can be found in the 
oral cavity and gastrointestinal tract and is more prevalent in 
the saliva of patients with alcohol abuse (23). Although we 
report a higher bacteremia rate in the emergency endoscopy 
without variceal therapy (control) group (10.3%) compared 
with the emergency EVS group (2.3%), this may not be clinically 
significant bacteremia.
We recently published a meta-analysis on bacteremia after both 
EVL and EVS and found only limited data on bacteremia after 
EVL (24). The data in this study had not yet been reported and so 
was not included in the meta-analysis. There have been reports 
of transient bacteremia after both EVL and EVS (6, 8, 16, 21, 25). 
The incidence of infectious adverse events after EVL may be lower 
than that for EVS, although the existing data are conflicting. Early 
studies reported higher transient bacteremia in the EVS group 
than the EVL group that was statistically significant, 17.2% in EVS 
compared with 3.3% in EVL (p < 0.03) (6), or not statistically sig-
nificant, 40% in EVS compared with 25% in EVL (16). However, 
most recent studies have found higher rates of positive blood 
cultures in EVL compared with EVS group [5.7% in EVL com-
pared with 4.6% in EVS (25), 4.6% in EVL compared with 0.0% 
in EVS (21)]. In the present study, postendoscopic bacteremia 
was detected only in emergent EVS and emergency endoscopy 
without variceal therapy groups (10.3%), but not in EVL group.
The risks of transient bacteremia are different in emergency 
and elective procedures (11, 16). In general, patients with acute 
presentations are usually sicker. Patients with active or recent 
bleeding may have variceal walls more susceptible to bacterial 
invasion. In one study, none of the patients developed bactere-
mia after the elective cyanoacrylate injection for EVS, whereas 
bacteremia was significantly higher in patients who presented for 
emergency EVS to control variceal bleeding (15% at 5 min and 
10% at 3 h) (26). Our study detected postendoscopic bacteremia 
only in emergency sessions, but not in any elective sessions. 
The difference may be real but could be due to the insufficient 
numbers of subjects in the studies.
Although some studies conducted the blood culture at differ-
ent time frames, such as longer after endoscopic therapy, most 
previous studies detected positive blood cultures within 1  h 
after endoscopy. Therefore, our study design for blood cultures 
at 5 min (BCX2) and 30 min (BCX3) after the endoscopy was 
rational to detect the bacteremia after endoscopy.
Compared with EVL, EVS has been associated with a higher 
risk of various adverse events, including pleuropulmonary, bleed-
ing, and infective events (27–29). In the present study, we did 
not find significant complications after endoscopic procedures, 
except pneumonia with a positive sputum culture in one patient. 
One patient had abdominal pain and leukocytosis before endos-
copy and developed culture negative SBP in the hospital after 
endoscopy, which is may due to pre-existing SBP.
Limitations of our study include the relatively small numbers 
of patients in each group and limited power for the demonstra-
tion of statistically significant differences. This study was initiated 
soon after the introduction of the single band ligator and, there-
fore, did not study the risk of bacteremia after EVL using current 
multiband ligators (30, 31). However, most studies of bacteremia 
after banding have been done with single band ligators, so that 
the data on bacteremia after multiband esophageal ligation are 
limited, and none of the studies utilize the current equipment 
popular in the United States.
In conclusion, our findings are consistent with a low risk 
of bacteremia after EVL. We found no bacteremia after either 
elective or emergency variceal ligation. Bacteremia occurred in 
emergency sclerotherapy, but was infrequent, and we found no 
bacteremia after elective sclerotherapy. These results add more 
information for use in guidelines on the risk of bacteremia after 
variceal ligation (5, 13, 14).
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